The world will truly break through the bottleneck of the development of medical devices, deep into the basic disciplines such as clinical research, new materials and technology, and accelerate the tec

Medical Network September 7 News

According to the "2018-2020 China Big Health Industry Investment Research Report" Data: Since entering the 21st century, China's medical device industry has entered a high-speed growth stage, the total scale of sales from 2001 of 17.9 billion yuan, to 2014 about 255.6 billion yuan, the growth of 14.28 times times.

2010 to 2016, the domestic medical device market size from 2010 to 126 billion yuan growth to 370 billion yuan in 2016, the annual compound growth rate of 19.67%, 2017 China Medical Device market scale has reached 448.4 billion yuan.

2011-2017 China Medical Device market scale (billion yuan)

While sales of domestic medical devices are growing rapidly, the 2015 Drug and medical device consumption ratio is only 1:0.33, far below 1:0.7 of the global average, less than 1.02:1 of the level of developed countries, so the domestic medical device market development prospects, the market is far from saturation.

2011-2017 Global Medical Device sales volume (billion)

Lack of strategic positioning, lower than the high-end products, and Agent Business to compress profits synchronously. Competition is at a disadvantage, not enough profit to continue research and development, lack of financial support, and upgrading is also facing technical and financial pressure, market brand investment is insufficient. 2, a single technology breakthrough is difficult to form a platform advantage.

Lack of long-term technology portfolio, diluted customer development costs, not to invest in training and development of customers. 3, there are technical details gaps in the process of simple imitation. Unlike God, the quality is uneven, with the production of imported products localized, domestic enterprises should really grasp the technology and product development ideas.

Key raw materials, high-precision processing equipment and technical mastery can significantly shorten the gap.

4, quality control put forward higher requirements. Medical devices Safety in front of the benefits, product development and technology change phase to verify and confirm repeatedly, the system must ensure that the product of batch stability, and can continue to improve. According to the State administration of Food and Drug Administration official website, January 1, 2018, the release of the "Medical Device clinical trial agency conditions and records management measures" has formally begun to implement.

China's medical device market scale and foreign existence a certain gap, but the growth rate is amazing:

The global market for medical devices was $406.3 billion trillion in 2016, with the largest market in the United States reaching US $208.4 billion, while China's market size is 370 billion yuan, accounting for 1/6 of global markets, and the US has only 6.03% growth in medical devices, while China's growth rate is around 19.67%.

Global Medical Devices account for Medicine The total market size of 42%, and China's medical devices accounted for the total size of the pharmaceutical market 9.16%, the Chinese medical device industry has a lot of room for development.

Medical Devices in China Enterprise Revenue is a big gap from the US, but it is growing much faster than the US and global averages. In 2016, China TOP10 's medical device business grew 30% from a year earlier, compared with 6.84% in the US. There is a big gap between absolute and relative investment compared to the United States: in 2016, the U.S. medical device revenue TOP10 Company invested $10.4 billion in research and development, accounting for 8.14% of total revenue.

Over the same period, the total investment in research and development of Chinese medical device revenue TOP10 was 1.806 billion yuan, accounting for 5.35% of total revenue. Research and development gap at home and abroad mainly reflected in: insufficient volume, product originality, technical details, core materials and key components.

Domestic industry and clinical needs of the cooperative research and development model is gradually maturing, the original product is relatively scarce.

Three, the next three years, in vitro diagnosis, neurology, cardiac devices sub-market development space full of imagination

In-vitro diagnostics continue to lead the medical device, accounting for 13.1% of the total sales volume of the industry, by 2020, in vitro diagnostics will remain the largest sub-market in the medical device market. Heart-like medical devices can be ranked second, followed by a number of traditional industries, such as diagnostic imaging, orthopedics and ophthalmology.

Neurology is the fastest growing sub-city in medical devices.

The medical device market is growing rapidly, but also because many diseases drugs are difficult to solve, so medical diagnosis, nerve regulation and so on will contribute to the diagnosis and treatment of the disease. Overall, investment in medical innovation technology will be the future trend. China's future market, domestic import substitution is the trend, the national policy is also tilted to domestic equipment. Overseas, cost-effective China manufacturing will be a global challenge to major international brands as soon as possible.

The world will truly break through the bottleneck of the development of medical devices, deep into the basic disciplines such as clinical research, new materials and technology, and accelerate the technology iteration, combining with emerging disciplines such as artificial intelligence. 450 billion! China overtook Japan to become the world's second largest medical machinery market!